Soliton, Inc. (SOLY) 是一家上市公司 属于 医疗保健 板块，经营于 Medical - Devices 行业. 公司总部位于 Houston, TX, 美国. 现任CEO为 Christopher C. Capelli.
SOLY 拥有 IPO日期为 2019-02-19, 13 名全职员工, 在 NASDAQ Capital Marke.
Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications. The company was incorporated in 2012 and is based in Houston, Texas. As of December 16, 2021, Soliton, Inc. operates as a subsidiary of Allergan plc.
